Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2003
11/06/2003WO2003090757A1 Pharmaceutical compositions of phospholipid derivatives
11/06/2003WO2003090756A1 Anti-acne compositions and methods of use
11/06/2003WO2003090755A1 Treatment of hypertension in women receiving hormone replacement therapy
11/06/2003WO2003090754A1 Use of dhea for treatment of female hypopituitarism
11/06/2003WO2003090753A1 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
11/06/2003WO2003090752A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003WO2003090751A1 Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
11/06/2003WO2003090750A1 Pdgf receptor tyrosine kinase inhibitors for the treatment of polycythemia vera
11/06/2003WO2003090749A1 Use of berberine with high solubility in preparation of medicament
11/06/2003WO2003090748A1 Use of compounds having ccr antagonism
11/06/2003WO2003090747A1 Topical treatment of erectile dysfunction
11/06/2003WO2003090746A1 1,3-thiazoles as lxr modulators in the treatment of cardiovascular diseases
11/06/2003WO2003090745A1 Fxr agonists for hepatoprotection and treatment of cholestasis
11/06/2003WO2003090744A1 Antibacterial compositions comprising metal phthalocyanine analogues
11/06/2003WO2003090743A1 Prevention and treatment of functional somatic disorders, including stress-related disorders
11/06/2003WO2003090742A1 Pharmaceutical composition comprising a lipase inhibitor and glucomannan
11/06/2003WO2003090741A1 Hydrophilic and lipophilic silibinin pro-forms and their application
11/06/2003WO2003090740A1 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori
11/06/2003WO2003090739A1 Use of conjugated linoleic acid derivatives
11/06/2003WO2003090738A1 Stress inhibition composition, theanine-containing granule and process for producing the same
11/06/2003WO2003090737A2 Methods and compositions for treatment of cancer pain
11/06/2003WO2003090736A1 Novel carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
11/06/2003WO2003090735A1 Therapeutic agent for inflammatory intestinal diseases containing hydroxamic acid compound as active ingredient
11/06/2003WO2003090734A1 Tolterodine salts
11/06/2003WO2003090733A1 Inhibition of platelet aggregation
11/06/2003WO2003090732A1 Lxr modulators for the treatment of cardiovascular diseases
11/06/2003WO2003090731A1 Use of gabab receptor positive modulators in gastro-instestinal disorders
11/06/2003WO2003090730A1 Novel crystalline forms of celecoxib and other compounds
11/06/2003WO2003090729A1 Transdermal analgesic systems with reduced abuse potential
11/06/2003WO2003090728A1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix
11/06/2003WO2003090725A1 Capsule preparation
11/06/2003WO2003090723A1 Modified-release vasopeptidase inhibitor formulation, combinations and method
11/06/2003WO2003090722A2 Microparticle pharmaceutical compositions for intratumoral delivery
11/06/2003WO2003090721A2 Method for producing crystals from active ingredients in medicaments, and the use thereof in pharmaceutical formulations
11/06/2003WO2003090720A1 High drug load tablet
11/06/2003WO2003090714A1 Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulations
11/06/2003WO2003090712A2 Compositions for treating hyperemia
11/06/2003WO2003090711A1 Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine
11/06/2003WO2003090710A1 Lapachone delivery systems, compositions and uses related thereto
11/06/2003WO2003090708A1 External preparation for skin
11/06/2003WO2003090699A1 Cosmetic composition for promoting hair growth and/or preventing or delaying hair loss
11/06/2003WO2003090693A2 Pharmaceutical composition containing lamotrigine particles of defined morphology
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090686A2 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
11/06/2003WO2003090684A2 Polymer compositions containing a macrocyclic triene compound
11/06/2003WO2003090681A2 SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-κB INHIBITORS AND ANTI-NEOPLASTIC AGENTS
11/06/2003WO2003090679A2 11-deoxy azalide antibacterials
11/06/2003WO2003090678A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
11/06/2003WO2003090674A2 Compounds, compositions and methods for treating or preventing viral infections and associated diseases
11/06/2003WO2003090673A2 Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
11/06/2003WO2003090672A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
11/06/2003WO2003090671A2 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
11/06/2003WO2003090670A2 Moisturizing skin gel and method
11/06/2003WO2003090665A2 Regulation of erythrocyte apoptosis
11/06/2003WO2003090662A2 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/06/2003WO2003090560A1 Compositions comprising protein and fatty acid and processes of their preparation
11/06/2003WO2003090559A1 Compositions comprising milk protein concentrate and fatty acid and processes of their preparation
11/06/2003WO2003090558A1 Acidic compositions comprising protein and fiber and processes of their preparation
11/06/2003WO2003090557A1 Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight
11/06/2003WO2003090547A1 A composition comprising waxy acids for effecting serum cholesterol levels
11/06/2003WO2003090512A2 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/06/2003WO2003080125A3 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
11/06/2003WO2003080114A3 Imidazoquinoline adjuvants for vaccines
11/06/2003WO2003080112A3 Imidazoquinolineamines as adjuvants in hiv dna vaccination
11/06/2003WO2003079981A3 Bioadhesive drug delivery system
11/06/2003WO2003079970A3 4-(diarylmethyl)-1-piperazinyl derivatives
11/06/2003WO2003075685A3 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
11/06/2003WO2003072711A3 Method of using modified oligonucleotides for hepatic delivery
11/06/2003WO2003072025A3 Modified release formulations of at least one form of tramadol
11/06/2003WO2003070181A3 Compositions and methods for preservation of food
11/06/2003WO2003070171A3 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
11/06/2003WO2003068931A3 Purification of the leading front migratory cells
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003063793A3 Fatty acid-containing compositions and methods for the treatment of cytokine mediated disorders
11/06/2003WO2003061574A3 Prevention of cisplatin induced deafness
11/06/2003WO2003061557A3 Levothyroxine pharmaceutical compositions, methods of making and methods of administration
11/06/2003WO2003061556A3 Ingestible capsaicin neutralizer
11/06/2003WO2003060799A3 Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
11/06/2003WO2003059193A3 Use of nanoparticles as carriers for biocides in ophthalmic compositions
11/06/2003WO2003057670A3 Indoles as naaladase inhibitors
11/06/2003WO2003057166A3 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
11/06/2003WO2003057007A3 System for monitoring bacterial tumor treatment
11/06/2003WO2003055983A3 Targeted retrograde gene delivery to motor neurons
11/06/2003WO2003055880A3 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same
11/06/2003WO2003054541A3 Inhibition of tristetraproline for protection of the heart from cardiac injuries
11/06/2003WO2003053999A3 Selective arylguanidine peptides as urokinase inhibitors
11/06/2003WO2003049688A3 Bis hydrochloride monohydrate salt of rsv fusion inhibitor
11/06/2003WO2003049637A3 In situ bonds
11/06/2003WO2003039539A3 Use of endothelin receptor antagonists in the treatment of tumour diseases
11/06/2003WO2003039455A3 Methods of treating endometreosis
11/06/2003WO2003038036A3 Rescue of gonadotropin releasing hormone receptor mutants
11/06/2003WO2003035626A3 Azole derivatives and pharmaceutical compositions containing them
11/06/2003WO2003035005A3 Heteroindanes: a new class of potent cannabimimetic ligands
11/06/2003WO2003035004A3 Immunotherapy for reversing immune suppression
11/06/2003WO2003034900A3 Sterile, breathable patch for treating wound pain
11/06/2003WO2003032985A3 Concomitant oral and topical administration of anti - infective agents
11/06/2003WO2003032903A3 Trisubstituted triazines compounds with antitubulin activity
11/06/2003WO2003032804A3 Reversing or preventing premature vascular senescence
11/06/2003WO2003030934A3 Cpg formulations and related methods
1 ... 5283 5284 5285 5286 5287 5288 5289 5290 5291 5292 5293 5294 5295 5296 5297 5298 5299 5300 5301 5302 5303 ... 7860